{
	"kihkd27rText": "Bri<span class=\"_ _1\"></span>ntel<span class=\"_ _1\"></span>lix<span class=\"_ _1\"></span>® sig<span class=\"_ _1\"></span>nifica<span class=\"_ _1\"></span>ntly imp<span class=\"_ _1\"></span>ro<span class=\"_ _1\"></span>ve<span class=\"_ _1\"></span>s ph<span class=\"_ _1\"></span>ysi<span class=\"_ _1\"></span>cal <br><span class=\"ls20 ws29\">symptoms in patients<span class=\"_ _4\"></span> with MDD<span class=\"_ _1\"></span><span class=\"fs3 ls0 v1\">1</span></span>",
	"kihkd28hText": "MDD",
	"kihkd28iText": "Study Design",
	"kihkd28jText": "Zoom",
	"Brintellix_21704c3a1e": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\"><div style=\"text-align: center;\">4. Insomnia</div><div style=\"text-align: center;\">Early</div></font>",
	"Brintellix_21312ed45e": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">5. Insomnia</div>\n<div style=\"text-align: center;\">Middle</div>\n</font>",
	"Brintellix_212cd1d584": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">6. Insomnia</div>\n<div style=\"text-align: center;\">Late</div>\n</font>",
	"Brintellix_21de9a12ff": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">11. Anxiety</div>\n<div style=\"text-align: center;\">Somatic</div>\n</font>",
	"Brintellix_21d22f7cb8": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">12. Somatic</div>\n<div style=\"text-align: center;\">Symptoms-</div>\n<div style=\"text-align: center;\">Gastointestinal</div>\n</font>",
	"Brintellix_21173bafa9": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">13. Somatic</div>\n<div style=\"text-align: center;\">Symptoms-</div>\n<div style=\"text-align: center;\">General</div>\n</font>",
	"Brintellix_219d36d17e": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">14. Genital</div>\n<div style=\"text-align: center;\">Symptoms</div>\n</font>",
	"Brintellix_2172bf0d6f": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">16. Loss of</div>\n<div style=\"text-align: center;\">Weight</div>\n</font>",
	"Brintellix_212edc22fa": "<span style=\"font-family: &quot;1_WUORLG+AvenirNextLTPro-Bold&quot;; color: rgb(77, 127, 134);\"><font style=\"font-size: 20px;\"><div style=\"text-align: center;\">Meta analysis of change from baseline</div><div style=\"text-align: center;\">in HAM-D single items at week 6/8 (FAS, MMRM, SES)&nbsp;</div></font></span>",
	"Brintellix_21f27ab687": "<span style=\"font-family: &quot;1_WUORLG+AvenirNextLTPro-Bold&quot;; color: rgb(77, 127, 134);\"><font style=\"font-size: 14px;\">\nDifference to placebo\n</font></span>",
	"Brintellix_2187c427f1": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n*p&lt;0.05; **p&lt;0.01; ***p&lt;0.001\n</font>",
	"Brintellix_217c4d9027": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\nBrintellix<sup><small>®</small></sup> 5 mg (n=108)\n</font>",
	"Brintellix_2134d86ef1": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\nBrintellix<sup><small>®</small></sup>&nbsp;10 mg (n=100)\n</font>",
	"Brintellix_21abb40e8b": "<font style=\"font-size: 11px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.2;display:inline-block;\">\n<p style=\"margin-bottom: 8px;\">Study population – 2105  adult MDD outpatients (18-75 years of age) with a major depressive episode of ≥3 months ’duration <br>\nMeta analysis from five studies – Alvarez, et al 2012, Baldwin et al, 2012, Henigsberg, et al 2012, Jain, et al 2013, <br>\nMahabaleshwarkar, et al 2013</p>\n\n<p style=\"margin-bottom: 0;margin-top: 4px;\">Definition of HAM-D items</p>\n<p style=\"margin-bottom: 0;margin-top: 4px;\">Item 4 – Insomnia Early – complains of occasional difficulty falling asleep; i.e. more than ½ hour, or complains of nightly difficulty <br>falling asleep; Scores are assigned as Absent=0, Occasional=+1, Frequent=+2</p>\n<p style=\"margin-bottom: 0;margin-top: 4px;\">Item 5 – Insomnia Middle – Patient complains of being restless and disturbed during the night or waking during the night; <br>Scores are assigned as Absent=0, Occasional=+1, Frequent=+2</p>\n<p style=\"margin-bottom: 0;margin-top: 4px;\">Item 6 – Insomnia Late – waking in early hours of the morning but goes back to sleep or unable to fall asleep again if getting out <br>of bed; Scores are assigned as Absent=0, Occasional=+1, Frequent=+2</p>\n<p style=\"margin-bottom: 0;margin-top: 4px;\">Item 11 – Anxiety Somatic – physiological concomitants of anxiety, such as gastrointestinal – dry mouth, wind, indigestion, <br>diarrhoea, cramps, \tbelching, cardiovascular (palpitations, headache), respiratory (hyperventilation, sighing, urinary frequency, <br>sweating); Scores are assigned as Absent=0, Mild=+1, Moderate=+2, Severe=+3, Incapacitating=+4</p>\n<p style=\"margin-bottom: 0;margin-top: 4px;\">Item 12 – Somatic Symptoms – Gastrointestinal – loss of appetite but eating without staff encouragement, heavy feelings in <br>abdomen, difficulty eating without staff urging, requests or requires laxatives or medication for bowels or medication for GI <br>symptoms; Scores are assigned as Absent=0, Mild=+1, Severe=+2</p>\n<p style=\"margin-bottom: 0;margin-top: 4px;\">Item 13 – Somatic Symptoms – General – heaviness in limbs, back or head, backaches, headache, muscle aches, loss of energy <br>and fatigability; Scores are assigned as Absent=0, Mild=+1, Severe=+2</p>\n<p style=\"margin-bottom: 0;margin-top: 4px;\">Item 14 – Genital Symptoms – symptoms such as loss of libido or menstrual disturbances; Scores are assigned as Absent=0, <br>Mild=+1, Severe=+2</p>\n<p style=\"margin-bottom: 10px;\">Item 16 – Loss of Weight – probable weight loss associated with present illness or definite (according to patient) weight loss; <br>Scores are assigned as None=0, Slight=+1, Obvious/Severe=+2</p>\n\nHAM-D=Hamilton Depression rating scale; HAM-A=Hamilton Anxiety rating scale, FAS=Full analysis set, MMRM=mixed model <br>repeated measurements, SES=standardised estimates\n</font>",
	"Brintellix_218e5abe8f": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\"><div style=\"text-align: center;\">4. Insomnia</div><div style=\"text-align: center;\">Early</div></font>",
	"Brintellix_21a2809b2b": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">5. Insomnia</div>\n<div style=\"text-align: center;\">Middle</div>\n</font>",
	"Brintellix_21b0b7d8b8": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">6. Insomnia</div>\n<div style=\"text-align: center;\">Late</div>\n</font>",
	"Brintellix_21cb4fa6fe": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">11. Anxiety</div>\n<div style=\"text-align: center;\">Somatic</div>\n</font>",
	"Brintellix_217bcfcc00": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">12. Somatic</div>\n<div style=\"text-align: center;\">Symptoms-</div>\n<div style=\"text-align: center;\">Gastointestinal</div>\n</font>",
	"Brintellix_21810134cc": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">13. Somatic</div>\n<div style=\"text-align: center;\">Symptoms-</div>\n<div style=\"text-align: center;\">General</div>\n</font>",
	"Brintellix_215a25d298": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">14. Genital</div>\n<div style=\"text-align: center;\">Symptoms</div>\n</font>",
	"Brintellix_21a0b806e3": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">16. Loss of</div>\n<div style=\"text-align: center;\">Weight</div>\n</font>",
	"Brintellix_212287d1bd": "<span style=\"font-family: &quot;1_WUORLG+AvenirNextLTPro-Bold&quot;; color: rgb(77, 127, 134);\"><font style=\"font-size: 20px;\"><div style=\"text-align: center;\">Meta analysis of change from baseline</div><div style=\"text-align: center;\">in HAM-D single items at week 6/8 (FAS, MMRM, SES)&nbsp;</div></font></span>",
	"Brintellix_21519df952": "<span style=\"font-family: &quot;1_WUORLG+AvenirNextLTPro-Bold&quot;; color: rgb(77, 127, 134);\"><font style=\"font-size: 14px;\">\nDifference to placebo\n</font></span>",
	"Brintellix_2129b99e65": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n*p&lt;0.05; **p&lt;0.01; ***p&lt;0.001\n</font>",
	"Brintellix_21b6082c5f": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\nBrintellix<sup><small>®</small></sup> 5 mg (n=108)\n</font>",
	"Brintellix_213dc27d06": "<font style=\"font-size: 11.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\nBrintellix<sup><small>®</small></sup> 10 mg (n=100)\n</font>",
	"Brintellix_21876d013d": "<font style=\"font-size: 10.5px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.2;display:inline-block;\">\n<p style=\"margin-bottom: 1px;margin-top: 5px;\">Study population – 823/2105 adult MDD outpatients (18-75 years of age) with a major depressive episode of ≥3 months ’duration <br>and a HAM-A score ≥20 <br>\nMeta analysis from five studies – Alvarez, et al 2012, Baldwin et al, 2012, Henigsberg, et al 2012, Jain, et al 2013, Mahabaleshwarkar, et al <br>\n2013 <br>\nDefinition of HAM-D items</p>\n\n<p style=\"margin-bottom: 1px;margin-top: 5px;\">Item 4 – Insomnia Early – complains of occasional difficulty falling asleep; i.e. more than ½ hour, or complains of nightly difficulty <br>falling asleep; Scores are assigned as Absent=0, Occasional=+1, Frequent=+2\n</p>\n<p style=\"margin-bottom: 1px;margin-top: 5px;\">Item 5 – Insomnia Middle – Patient complains of being restless and disturbed during the night or waking during the night; <br>Scores are assigned as Absent=0, Occasional=+1, Frequent=+2\n</p>\n<p style=\"margin-bottom: 1px;margin-top: 5px;\">Item 6 – Insomnia Late – waking in early hours of the morning but goes back to sleep or unable to fall asleep again if getting out of <br>bed; Scores are assigned as Absent=0, Occasional=+1, Frequent=+2\n</p>\n<p style=\"margin-bottom: 1px;margin-top: 5px;\">Item 11 – Anxiety Somatic – physiological concomitants of anxiety, such as gastrointestinal – dry mouth, wind, indigestion, <br>diarrhoea, cramps, \tbelching, cardiovascular (palpitations, headache), respiratory (hyperventilation, sighing, urinary frequency, <br>sweating); Scores are assigned as Absent=0, Mild=+1, Moderate=+2, Severe=+3, Incapacitating=+4\n</p>\n<p style=\"margin-bottom: 1px;margin-top: 5px;\">Item 12 – Somatic Symptoms – Gastrointestinal – loss of appetite but eating without staff encouragement, heavy feelings in <br>abdomen, difficulty eating without staff urging, requests or requires laxatives or medication for bowels or medication for GI <br>symptoms; Scores are assigned as Absent=0, Mild=+1, Severe=+2\n</p>\n<p style=\"margin-bottom: 1px;margin-top: 5px;\">Item 13 – Somatic Symptoms – General – heaviness in limbs, back or head, backaches, headache, muscle aches, loss of energy <br>and fatigability; Scores are assigned as Absent=0, Mild=+1, Severe=+2\n</p>\n<p style=\"margin-bottom: 1px;margin-top: 5px;\">Item 14 – Genital Symptoms – symptoms such as loss of libido or menstrual disturbances; Scores are assigned as Absent=0, <br>Mild=+1, Severe=+2\n</p>\n<p style=\"margin-bottom: 1px;margin-top: 5px;\">Item 16 – Loss of Weight – probable weight loss associated with present illness or definite (according to patient) weight loss; <br>Scores are assigned as None=0, Slight=+1, Obvious/Severe=+2\n</p>\nHAM-D=Hamilton Depression rating scale; HAM-A=Hamilton Anxiety rating scale, FAS=Full analysis set, MMRM=mixed model <br>repeated measurements, SES=standardised estimates\n</font>",
	"Brintellix_213bb9e7a7": "<span style=\"font-family: &quot;1_WUORLG+AvenirNextLTPro-Bold&quot;; color: rgb(77, 127, 134);\"><font style=\"font-size: 22.5px;\"><div style=\"text-align: center;\">Meta analysis of change from baseline</div><div style=\"text-align: center;\">in HAM-D single items at week 6/8 (FAS, MMRM, SES)&nbsp;</div></font></span>",
	"Brintellix_2196b837f1": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\"><div style=\"text-align: center;\">4. Insomnia</div><div style=\"text-align: center;\">Early</div></font>",
	"Brintellix_215b0d4e75": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">5. Insomnia</div>\n<div style=\"text-align: center;\">Middle</div>\n</font>",
	"Brintellix_21d7cabcd6": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">6. Insomnia</div>\n<div style=\"text-align: center;\">Late</div>\n</font>",
	"Brintellix_217dc64004": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">11. Anxiety</div>\n<div style=\"text-align: center;\">Somatic</div>\n</font>",
	"Brintellix_21f8899e4a": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">12. Somatic</div>\n<div style=\"text-align: center;\">Symptoms-</div>\n<div style=\"text-align: center;\">Gastointestinal</div>\n</font>",
	"Brintellix_215ccc796b": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">13. Somatic</div>\n<div style=\"text-align: center;\">Symptoms-</div>\n<div style=\"text-align: center;\">General</div>\n</font>",
	"Brintellix_2197adc74d": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">14. Genital</div>\n<div style=\"text-align: center;\">Symptoms</div>\n</font>",
	"Brintellix_21a5bcaf35": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">16. Loss of</div>\n<div style=\"text-align: center;\">Weight</div>\n</font>",
	"Brintellix_2144061f91": "<span style=\"font-family: &quot;1_WUORLG+AvenirNextLTPro-Bold&quot;; color: rgb(77, 127, 134);\"><font style=\"font-size: 14px;\">\nDifference to placebo\n</font></span>",
	"Brintellix_21bf3ea637": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\nBrintellix<sup><small>®</small></sup> 5 mg (n=108)\n</font>",
	"Brintellix_2157516566": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\nBrintellix<sup><small>®</small></sup> 10 mg (n=100)\n</font>",
	"Brintellix_219150f17a": "<span style=\"font-family: &quot;1_WUORLG+AvenirNextLTPro-Bold&quot;; color: rgb(77, 127, 134);\"><font style=\"font-size: 22.5px;\"><div style=\"text-align: center;\">Meta analysis of change from baseline</div><div style=\"text-align: center;\">in HAM-D single items at week 6/8 (FAS, MMRM, SES)&nbsp;</div></font></span>",
	"Brintellix_214669b681": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\"><div style=\"text-align: center;\">4. Insomnia</div><div style=\"text-align: center;\">Early</div></font>",
	"Brintellix_21eaa7a49a": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">5. Insomnia</div>\n<div style=\"text-align: center;\">Middle</div>\n</font>",
	"Brintellix_21dd9ad953": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">6. Insomnia</div>\n<div style=\"text-align: center;\">Late</div>\n</font>",
	"Brintellix_21a5cebf4f": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">11. Anxiety</div>\n<div style=\"text-align: center;\">Somatic</div>\n</font>",
	"Brintellix_2113f56813": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">12. Somatic</div>\n<div style=\"text-align: center;\">Symptoms-</div>\n<div style=\"text-align: center;\">Gastointestinal</div>\n</font>",
	"Brintellix_218deda5d0": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">13. Somatic</div>\n<div style=\"text-align: center;\">Symptoms-</div>\n<div style=\"text-align: center;\">General</div>\n</font>",
	"Brintellix_216a7e4bfc": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">14. Genital</div>\n<div style=\"text-align: center;\">Symptoms</div>\n</font>",
	"Brintellix_2176e5c681": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\n<div style=\"text-align: center;\">16. Loss of</div>\n<div style=\"text-align: center;\">Weight</div>\n</font>",
	"Brintellix_21f4372f54": "<span style=\"font-family: &quot;1_WUORLG+AvenirNextLTPro-Bold&quot;; color: rgb(77, 127, 134);\"><font style=\"font-size: 14px;\">\nDifference to placebo\n</font></span>",
	"Brintellix_21e5568f6b": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\nBrintellix<sup><small>®</small></sup> 5 mg (n=108)\n</font>",
	"Brintellix_21d3f03e7b": "<font style=\"font-size: 13px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\">\nBrintellix<sup><small>®</small></sup> 10 mg (n=100)\n</font>",
	"Brintellix_21d67bb03a": "<span style=\"font-family: &quot;1_WUORLG+AvenirNextLTPro-Bold&quot;; color: rgb(232, 87, 0);\"><font style=\"font-size: 22px;\">All patients</font></span>",
	"Brintellix_21a90e3956": "<span style=\"color: rgb(77, 127, 134); font-family: &quot;15_VDWFON+AvenirNextLTPro-Demi&quot;; line-height: 1;\"><font style=\"font-size: 22.5px;\">Patients with<br style=\"\">a HAM-A <b>≥&nbsp;</b>20 at baseline</font></span>",
	"Brintellix_216d48cfb4": "Text",
	"Brintellix_21c4830382": "Text",
	"Brintellix_2124604c6e": "<span style=\"color: rgb(77, 127, 134); font-family: '15_VDWFON+AvenirNextLTPro-Demi';\"><font style=\"font-size: 22.5px;\">References</font></span>",
	"Brintellix_21a5b9b958": "<font style=\"font-size: 15px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);line-height: 1.3;display:inline-block;\"><b>\n1.</b> Christensen MC et al. J Psychopharmacol 2018;32:1086-1097.\n</font>",
	"Brintellix_214583d796": "Text",
	"Brintellix_219de60d3c": "Text",
	"Brintellix_211b89ec32": "Text",
	"Brintellix_214574eb33": "Text",
	"Brintellix_21fc59dd6d": "Text",
	"Brintellix_218edcbccf": "Text",
	"Brintellix_215346aac6": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;background-color: #e5f0f2;box-sizing: border-box;color: #4d7f86;\">\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">MADRS 10</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;color: #fff;background: rgb(233,90,0);background: linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);background: -webkit-linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);\">Physical symptoms</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Remission</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Relapse prevention</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Short term</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Long term</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Meta-analysis</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4px 12px 3px;line-height:1.3;background-color: #e5f0f2;\">Suboptimal responses<br>to SSRI/SNRI</div>\n</div>",
	"Brintellix_21f415cf8f": "Text"
}
